Showing results (41-50 of 123) with videos related to

Sort By:
Pageof 13
Radiation Medicine|June 22, 2007
Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammographyMiho I Yoshikawa, Shozo Ohsumi, Shigenori Sugata, et al.
Breast Cancer Research : BCR|October 28, 2020
Prevalence of germline BRCA mutations in HER2-negative metastatic breast cancer: global results from the real-world, observational BREAKOUT studyJoyce O'Shaughnessy, Christine Brezden-Masley, Marina Cazzaniga, et al.
Annals of Surgery|July 4, 2012
Evaluation of the usefulness of breast CT imaging in delineating tumor extent and guiding surgical management: a prospective multi-institutional studySadako Akashi-Tanaka, Nobuaki Sato, Shozo Ohsumi, et al.
Breast Cancer (Tokyo, Japan)|December 6, 2006
A case of metastatic breast cancer with HER2 gene amplification that responded completely to single agent trastuzumabYasuhiro Tsutani, Shozo Ohsumi, Kenjiro Aogi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 22, 2009
[Correlations between hormonal receptor and HER2 status or nuclear grades and response rate in breast cancer treated with neoadjuvant chemotherapy of docetaxel alone]Takahiro Mimae, Naruto Taira, Shozo Ohsumi, et al.
Breast Cancer (Tokyo, Japan)|March 7, 2006
Non-palpable ductal carcinoma in situ (DCIS) with microinvasion arising in a radial scar presenting with spiculation alone on mammograms: a case reportAtsushi Okita, Shozo Ohsumi, Shigemitsu Takashima, et al.
Oncology Letters|March 20, 2015
Clinical experience with nanoparticle albumin-bound paclitaxel, a novel taxane anticancer agent, and management of adverse events in females with breast cancerSeiki Takashima, Sachiko Kiyoto, Mina Takahashi, et al.
Oncology|March 5, 2011
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institutionFumikata Hara, Sachiko Kiyoto, Mina Takahashi, et al.
Breast Cancer Research and Treatment|February 25, 2011
Health-related quality of life and psychological distress of breast cancer patients after surgery during a phase III randomized trial comparing continuation of tamoxifen with switching to anastrozole after adjuvant tamoxifen for 1-4 years: N-SAS BC 03Shozo Ohsumi, Kojiro Shimozuma, Yasuo Ohashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 22, 2008
[Efficacy of vinorelbine monotherapy in advanced and metastatic breast cancer]Hiroshi Suehisa, Kenjiro Aogi, Fumikata Hara, et al.
Pageof 13